Larvol Delta - A-Study-of-IMR687-in-Subjects-With-Sickle-Cell-Disease

tovinontrine (IMR-687) - Enliven Therapeutics

http://clinicaltrials.gov/ct2/show/NCT04474314

May 15, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next